Irvine-based Biogennix, a leader in advanced bone regeneration technology, today announced that its DirectCell® As of this quarter, the Advanced Bone Grafting System has been used in more than 1,000 cases.
“It was rewarding to see our DirectCell system so well received in the surgical community”
tweet this
The DirectCell System includes an advanced synthetic bone graft material with properties that enhance cellular bone formation, along with new instruments designed to collect high concentrations of stem cells from patients. This provides surgeons with an optimal biological graft that jump-starts the bone regeneration process.
“It was rewarding to see our DirectCell system so well received in the surgeon community,” said Scott Bauccio, Biogennix Vice President of Sales and Business Development. “We designed this system specifically to provide surgeons and hospitals with a comprehensive bone grafting solution that includes a stem cell harvesting system and autografts in one product. Feedback was consistently positive across multiple market segments, including both the spine and foot and ankle surgery categories. We attribute the rapid success of the DirectCell system primarily to the solid science supporting its benefits and expect continued growth of the system next year.”
The advanced bone graft within the system is Biogennix’s premium product, Agilon®, which is available in a moldable and strip form. Agilon products are based on Biogennix’s unique TrelCor technology which contains a nanocrystalline hydroxycarbanoapatite (HCA) graft surface that actively promotes bone regeneration.
The DirectCell system also offers surgeons two methods for collecting bone marrow-derived stem cells, either by harvesting stem cell aspirate (SCA), which has significantly higher stem cell counts compared to standard bone marrow aspirate (BMA), or by using marrow-rich autograft. dowels. Together, the technologies within the DirectCell System allow surgeons to harness both advanced synthetic material technology and the power of the patient’s own stem cells.
“The DirectCell system not only enables the harvest of clinically higher cell counts, but it is a safer and significantly more cost-effective alternative to previous standards of care,” said Bauccio. “When a procedure uses a patient’s own cells, the risk of disease transmission is completely eliminated.”
The DirectCell system is available with Biogennix, Agilon Moldable or Agilon Strip bioactive bone grafts.
Leave a Reply to Plums for your bones – Food for healthy bones – Knee Hurt Cancel reply